Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 95-110 , March 2008

Beta blockers and alpha2 agonists for cardioprotection

  • Martin J. London, MD (Professor of Clinical Anesthesia)

      Affiliations

    • Corresponding Author InformationTel.: +1 415 221 4810x3042; Fax: +1 415 750 6653.

References 

  1. Pasternack PF, Imparato AM, Baumann FG, et al. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation. 1987;76:III1–III7
  2. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. New England Journal of Medicine. 1996;335:1713–1720
  3. Devereaux PJ, Goldman L, Yusuf S, et al. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. Canadian Medical Association Journal. 2005;173:779–788
  4. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. New England Journal of Medicine. 1999;341:1789–1794
  5. Poldermans D, Boersma E, Bax JJ, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. European Heart Journal. 2001;22:1353–1358
  6. Dorman BH, Zucker JR, Verrier ED, et al. Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia. 1993;7:386–395
  7. Anon . Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. McSPI – Europe Research Group. Anesthesiology. 1997;86:346–363
  8. Oliver MF, Goldman L, Julian DG, Holme I. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology. 1999;91:951–961
  9. Wallace AW, Galindez D, Salahieh A, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology. 2004;101:284–293
  10. London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology. 2004;100:170–175
  11. Devereaux PJ, Yang H, Guyatt GH, et al. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. American Heart Journal. 2006;152:223–230
  12. London MJ, Zaugg M, Schaub MC, Spahn DR. A large trial is vital to prove perioperative beta-blockade effectiveness and safety before widespread use. Anesthesiology. 2004;101:804–805
  13. London MJ, Itani KM, Perrino AC, et al. Perioperative beta-blockade: a survey of physician attitudes in the Department of Veterans Affairs. Journal of Cardiothoracic and Vascular Anesthesia. 2004;18:14–24
  14. Nishina K, Mikawa K, Uesugi T, et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology. 2002;96:323–329
  15. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesthesia and Analgesia. 2003;97:623–633
  16. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. American Journal of Medicine. 2003;114:742–752
  17. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ (Clinical Research ed.). 2005;331:313–321
  18. McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?. Surgery. 2005;138:171–179
  19. Kapoor AS, Kanji H, Buckingham J, et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ (Clinical Research ed.). 2006;333:1149
  20. Schouten O, Shaw LJ, Boersma E, et al. A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coronary Artery Disease. 2006;17:173–179
  21. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative {beta}-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesthesia and Analgesia. 2007;104:27–41
  22. Merin RG. Anesthetic management problems posed by therapeutic advances: 3. Beta-adrenergic blocking drugs. Anesthesia and Analgesia. 1972;51:617–624
  23. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. New England Journal of Medicine. 2005;353:349–361
  24. Redelmeier D, Scales D, Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ (Clinical Research ed.). 2005;331:932
  25. Rinfret S, Abrahamowicz M, Tu J, et al. A population-based analysis of the class effect of beta-blockers after myocardial infarction. American Heart Journal. 2007;153:224–230
  26. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. American Journal of Medicine. 2007;120:26–32
  27. Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. New England Journal of Medicine. 2000;342:905–912
  28. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1622–1632
  29. McEniery CM, Schmitt M, Qasem A, et al. Nebivolol increases arterial distensibility in vivo. Hypertension. 2004;44:305–310
  30. van der Woude HJ, Zaagsma J, Postma DS, et al. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. Chest. 2005;127:818–824
  31. Kindermann M, Maack C, Schaller S, et al. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo. Circulation. 2004;109:3182–3190
  32. Mulder P, Barbier S, Chagraoui A, et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation. 2004;109:1674–1679
  33. Boudoulas H, Lewis RP, Rittgers SE, et al. Increased diastolic time: a possible important factor in the benefical effect of propranolol in patients with coronary artery disease. Journal of Cardiovascular Pharmacology. 1979;1:503–513
  34. Boudoulas H, Rittgers SE, Lewis RP, et al. Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation. 1979;60:164–169
  35. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation. 2001;104:1477–1482
  36. Feldman CL, Stone PH. Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Current Opinion in Cardiology. 2000;15:430–440
  37. Gertz SD, Roberts WC. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. American Journal of Cardiology. 1990;66:1368–1372
  38. Cheng GC, Loree HM, Kamm RD, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation. 1993;87:1179–1187
  39. Hutcheson IR, Griffith TM. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. The American Journal of Physiology. 1991;261:H257–H262
  40. Shechter M, Matetzky S, Feinberg MS, et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. Journal of the American College of Cardiology. 2003;42:2090–2095
  41. Balcells M, Fernandez Suarez M, Vazquez M, Edelman ER. Cells in fluidic environments are sensitive to flow frequency. Journal of Cellular Physiology. 2005;204:329–335
  42. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. New England Journal of Medicine. 2000;342:454–460
  43. Williams MJ, Low CJ, Wilkins GT, Stewart RA. Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture. Heart. 2000;84:377–382
  44. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ. 2006;332:1482
  45. Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. American Heart Journal. 2006;152:983–990
  46. Brady AR, Gibbs JS, Greenhalgh RM, et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. Journal of Vascular Surgery. 2005;41:602–609
  47. Zaugg M, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block. The Swiss Beta Blocker in Spinal Anesthesia (BBSA) Study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology. 2007;107:33–44
  48. Feringa HH, Bax JJ, Boersma E, et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation. 2006;114:I344–I349
  49. Poldermans D, Bax JJ, Schouten O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. Journal of the American College of Cardiology. 2006;48:964–969
  50. Khuri SF, Daley J, Henderson W, et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. Journal of the American College of Surgeons. 1995;180:519–531
  51. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 Guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy – a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesthesia and Analgesia. 2007;104:15–26
  52. Lionel H. Opie. Mechanisms of cardiac contraction and relaxation. Chapter 19 pages 457-489 in Braunwald's heart disease: a textbook of cardiovascular medicine, Seventh Edition, Elsevier Saunders. 2005.
  53. London MJ. Quo vadis, perioperative beta blockade? Are you “POISE’d” on the brink?”. Anesthesia Analgesia, in press. (editorial)
  54. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the non-cardiac surgical randomized trials. Anesthesia and Analgesia, in press.
  55. Biccard BM, Sear JW, Foex P. Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. British Journal of Anaesthesia. 2008;100:23–28

PII: S1521-6896(07)00088-2

doi: 10.1016/j.bpa.2007.09.008

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 95-110 , March 2008

Article Tools